Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Cory Watson is representing clients who have been diagnosed with cancer-related to breast implants. Over the past 25 years, we have helped more than 2300 women recover compensation for harms caused by breast implants.

According to the FDA, breast implants have been linked to a rare form of cancer known as Breast Implant-Associated Anaplastic Large Cell Lymphoma- also known as BIA-ALCL. The rare cancer is associated with both saline and silicone breast implants. FDA reported nine deaths associated with BIA-ALCL.

359 Cancer Cases Reported: 9 Deaths

The FDA has received 359 medical device reports associated with BIA-ALCL. ALCL is a lymphoma, a cancer of the immune system.  The breast implant-associated cancer is most often reported in tissue surrounding the site of the breast implants.

Symptoms of anaplastic large cell lymphoma related to breast implants may include:

  • Lumps
  • Fluid buildup and swelling around the implant site
  • Pain

Medical reporting indicates implant removal may eliminate the cancer, but some patients have needed chemotherapy and radiation to treat it.

If you develop symptoms of BIA-ALCL, contact your physician immediately.

Medical authorities emphasize that BIA-ALCL is an extremely rare type of cancer. According to a report by the American Society of Plastic Surgeons and the Plastic Surgery Foundation, more than 10 million women worldwide have received breast implants and it is estimated that fewer than 10 cases of BIA-ALCL are diagnosed each year. One study estimates the incidence at 1 in 300,000.

Facts From FDA

In 2011, the FDA identified a possible association between breast implants and the development of ALCL, a rare type of non-Hodgkin’s lymphoma.

As of February 1, 2017, the FDA had received:

  • 359 Medical Device Reports of Breast Implant-Associated ALCL
  • 9 reports of deaths caused by BIA-ALCL
  • 231 of the 359 reports included information on the surface type of the implants:
    • 203 are textured surface implants
    • 28 are smooth surface implants
  • 312 of the 359 reports included information on implant fill type:
    • 186 implants are filled with silicone gel
    • 126 implants are filled with saline
  • BIA-ALCL appears to develop more frequently in women with textured implants than in women with smooth-surfaced implants. Researchers have not identified an explanation for this.
  • Breast Implant-Associated ALCL has been associated with saline-filled breast implants and with silicone gel breast implants
  • The risk of developing ALCL remains very low for all women, though it is higher for women who have had breast implants.

The FDA recommends that breast implant recipients follow standard medical recommendations including following your doctor’s instructions on how to monitor your breast implants.  If you notice changes, contact your doctor promptly to schedule an appointment.

Contact Leila Watson of Cory Watson Attorneys Today

Over the past 25 years, Cory Watson has continuously represented more than 2300 women with breast implant-related injuries. If you or a loved one have been diagnosed with cancer-related to breast implants, Leila Watson is ready to help you get the compensation you deserve. Call (877) 562-0000 or fill out our online form to arrange for your FREE and CONFIDENTIAL case evaluation.

Leila H. Watson Website Footer

We’re Here For You 24/7

At Cory Watson Attorneys, we have made it our mission to fight for the rights of injury victims and their families for more than 30 years, and have recovered over $2.7 Billion. Our team of personal injury lawyers is ready to help you get the compensation you deserve if you or a loved one were harmed by breast implants.

Call (877) 562-0000 or fill out our online form to arrange for your FREE and CONFIDENTIAL case evaluation.